Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperbaric Oxygen as a Radiation Sensitizer for Locally Advanced Squamous Cell Carcinoma of the Oropharynx and Larynx
NCT03843671Phase 2Unknown
- Sponsor
- National Baromedical Services
- Start
- Jul 2019
- Primary completion
- Dec 2022
- Modality
- NPI (Non-Pharmacological Intervention)
- Countries
- 2
01
Overview
A Phase 2 trial of hyperbaric oxygen therapy in squamous cell carcinoma of the head and neck (HNSCC), sponsored by National Baromedical Services. Status: unknown.
02
Drugs
hyperbaric oxygen therapy
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT03843671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03843671.